Discontinued — last reported Q2 '23
Martin Marietta Materials Acquisitions decreased by 118.5% to -$20.00M in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -31.5% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $777.30M | $777.30M | $777.30M | -$18.80M | $7.80M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $488.00M | $2.05B | $0.00 | $1.10B | $0.00 | $0.00 | $577.00M | $108.00M | -$20.00M |
| QoQ Change | — | +0.0% | +0.0% | -102.4% | +141.5% | -100.0% | — | — | — | — | — | — | +320.1% | -100.0% | — | -100.0% | — | — | -81.3% | -118.5% |
| YoY Change | — | — | — | — | -99.0% | -100.0% | -100.0% | +100.0% | -100.0% | — | — | — | — | — | — | -100.0% | -100.0% | — | -90.2% | — |